Αποτελέσματα Αναζήτησης
16 Απρ 2019 · Neutropenia is associated with an increased risk of mortality and hospitalisation. Strategies, including the prescribing of colony-stimulating growth factors (CSFs), are adopted when a high risk (> 20%) of neutropenic complications are seen in the clinical trial setting.
13 Ιαν 2021 · The overall inpatient mortality was 2.3%, and was dependent on age (age 50-59 years—1.6% and age 80-89 years—5.3%). The median number of neutropenic inpatient episodes in each institution per year was 14 (range, 1-168).
The relative female predominance for neutropenia at age ≥ 60 years (934/1282; 73% of cases) was also consistent with relatively lower neutrophil levels for women in these age categories (mean, 3.0 ± 1.0 vs 3.3 ± 1.1 in males; P < .001) (Figure 1G-I). Unilineage, but not multilineage, cytopenias resolve in the majority of cases
29 Νοε 2010 · The average age of included patients was 59.8 years (range, 18-97 years) with 1445 (38.4%) aged 65 and older. Seventy percent (70%) of patients were female with breast cancer representing the most common malignancy (39%) followed by lung cancer (24%), colorectal (14%), lymphoma (15%), and ovary (8%).
15 Νοε 2022 · People with CND were more likely to be female (65%), be aged ≥18 years (91%), and have been seen by a hematologist (36%), as compared to other specialties. Among people aged <12 years, a greater proportion was diagnosed with congenital neutropenia (13%-20%) compared with cyclic neutropenia (5%-8%) or CIN (5%-6%) (Table).
28 Ιουν 2023 · The proportion of participants with neutropenia was higher in male individuals compared with female individuals across ethnic groups, 6.29% (95% CI: 5.00 − 7.59%) vs. 4.57% (95% CI: 3.59 − 5.54%) for black males and females, 0.66% (95% CI: 0.39 − 0.94%) vs. 0.64% (95% CI: 0.33 − 0.95%) for white males and females, 0.90% (95% CI: 0.54 ...
21 Αυγ 2014 · Isolated neutropenia is a common clinical problem seen by primary care physicians and hematologists. The evaluation of neutropenia is dictated by the acuity of the clinical presentation and the duration, age, and clinical status of the patient.
